Supported High-Risk Percutaneous Coronary Intervention With the Impella 2.5 Device. The Europella Registry

Journal of the American College of Cardiology

Volumn 54, Issue 25, 2009, Pages 2430-2434

  Sjauw, Krischan D ^a   Konorza, Thomas ^b   Erbel, Raimund ^b   Danna, Paolo L ^c   Viecca, Maurizio ^c   Minden, Hans Heinrich ^d   Butter, Christian ^d   Engstrøm, Thomas ^e   Hassager, Christian ^e   Machado, Francisco P ^f   Pedrazzini, Giovanni ^g   Wagner, Daniel R ^h   Schamberger, Rainer ⁱ   Kerber, Sebastian ⁱ   Mathey, Detlef G ^j   Schofer, Joachim ^j   Engström, Annemarie E ^a   Henriques, Jose P S ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

^d Heart Center Brandenburg in Bernau/Berlin   (Germany)

^e Mental Health Services CPH   (Denmark)

^f HOSPITAL DE SANTA CRUZ   (Portugal)

^g DIVISION OF CARDIOLOGY   (Switzerland)

^h Centre Hospitalier   (Luxembourg)

ⁱ Abteilung Kardiologie   (Germany)

^j UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

more..

Author keywords

high risk percutaneous coronary intervention; Impella 2.5; percutaneous left ventricular assist device; safety and feasibility

Indexed keywords

AGED; AORTA BALLOON; ARTICLE; BLEEDING; BLOOD TRANSFUSION; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEVICE INFECTION; DEVICE REMOVAL; FEMALE; HEART ASSIST DEVICE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STROKE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD TRANSFUSION; COMORBIDITY; CORONARY ARTERY DISEASE; EUROPE; FEASIBILITY STUDIES; FEMALE; HEART-ASSIST DEVICES; HEMORRHAGE; HUMANS; MALE; MYOCARDIAL INFARCTION; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 71649101773     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.018     Document Type: Article

References (10)

1. Sjauw K.D., Engström A.E., and Henriques J.P. Percutaneous mechanical cardiac assist in myocardial infarction. Where are we now, where are we going?. Acute Card Care 9 (2007) 222-230
2. Henriques J.P., Remmelink M., Baan Jr. J., et al. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5. Am J Cardiol 97 (2006) 990-992
3. Aragon J., Lee M.S., Kar S., and Makkar R.R. Percutaneous left ventricular assist device: "TandemHeart" for high-risk coronary intervention. Catheter Cardiovasc Interv 65 (2005) 346-352
4. Dixon S.R., Henriques J.P., Mauri L., et al. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (the PROTECT I trial). Initial U.S. experience. J Am Coll Cardiol Intv 2 (2009) 91-96
5. Burzotta F., Paloscia L., Trani C., et al. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study. J Cardiovasc Med (Hagerstown) 9 (2008) 1004-1010
6. Smith Jr. S.C., Feldman T.E., Hirshfeld Jr. J.W., et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 47 (2006) e1-e121
7. Mishra S., Chu W.W., Torguson R., et al. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol 98 (2006) 608-612
8. Briguori C., Airoldi F., Chieffo A., et al. Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. Am Heart J 152 (2006) 565-572
9. Burkhoff D., Cohen H., Brunckhorst C., O'Neill W.W., and TandemHeart Investigators Group. A randomized multicenter clinical study to evaluate the safety and efficacy of the TandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock. Am Heart J 152 (2006) 469.e1-469.e8
10. Thiele H., Smalling R.W., and Schuler G.C. Percutaneous left ventricular assist devices in acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 28 (2007) 2057-2063